RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • J&J beats forecasts, helped by new hepatitis C drug

    (Reuters) - Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market. Global...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors

    (Reuters) - Valeant Pharmaceuticals Inc moved on Friday to blunt a key criticism by takeover target Allergan Inc of its Bausch + Lomb business by releasing data showing strong sales growth. Allergan, which is trying to fend off a $51 billion hostile...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
  • Roche Alzheimer's drug fails main goals in mid-stage study

    ZURICH (Reuters) - Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given in earlier stages of the disease to slow patients' decline. The Swiss...
  • Ackman urges Allergan talks with Valeant, no delay to special meeting

    (Reuters) - Activist investor Bill Ackman urged Botox maker Allergan Inc to negotiate a possible takeover by Valeant Pharmaceuticals Inc and not delay a special shareholder meeting that could overturn most of Allergan's board. Ackman's Pershing Square...
  • AbbVie to buy drugmaker Shire for $55 billion

     AbbVie to buy drugmaker Shire for $55 billion
    AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom. The deal, announced by both companies in a...
  • Shire, AbbVie to announce $53 billion merger by Friday: sources

    Shire, AbbVie to announce $53 billion merger by Friday: sources
    (Reuters) - Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin-based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend...
  • FedEx indicted on charges of shipping drugs for illegal online pharmacies

    SAN FRANCISCO FedEX has been indicted by a federal grand jury on charges of shipping powerful prescription drugs for illegal online pharmacies, the latest major company targeted by federal law enforcement for playing a part in the proliferation of such...
  • Who gains from those drug discount deals? (Spoiler: Drug companies)

    The pharmaceutical industry has been bragging for nearly a decade now about its efforts to help cash-strapped patients pay for expensive prescription drugs.  "An important safety net," the industry says, that has "already helped millions of Americans...
  • AbbVie forced to retract claims of Shire investor support

    AbbVie forced to retract claims of Shire investor support
    AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his company's takeover bid for Shire Plc. The North Chicago-based pharmaceutical...